Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FUROSEMIDE SPECIAL | 10MG | SOLUTION | Resolved | 2017-11-28 | 2017-12-15 | 31051 |
| GEMCITABINE INJECTION | 40MG | SOLUTION | Resolved | 2022-12-12 | 2022-12-28 | 177927 |
| GEMCITABINE INJECTION | 40MG | SOLUTION | Resolved | 2019-07-24 | 2019-09-25 | 89859 |
| GEMCITABINE INJECTION | 40MG | SOLUTION | Resolved | 2017-08-07 | 2017-10-18 | 18317 |
| GENTAMICIN INJECTION USP | 40MG | SOLUTION | Resolved | 2023-01-19 | 2023-02-01 | 181682 |
| GENTAMICIN INJECTION USP | 40MG | SOLUTION | Resolved | 2022-12-12 | 2023-02-01 | 177924 |
| GENTAMICIN INJECTION USP | 40MG | SOLUTION | Resolved | 2023-03-02 | 2023-03-28 | 186057 |
| GENTAMICIN INJECTION USP | 10MG | SOLUTION | Resolved | 2023-07-04 | 2023-07-11 | 197061 |
| GENTAMICIN INJECTION USP | 10MG | SOLUTION | Resolved | 2017-08-07 | 2017-11-28 | 18394 |
| GENTAMICIN INJECTION USP | 40MG | SOLUTION | Resolved | 2017-08-07 | 2017-12-15 | 18397 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-11-13 | 2023-12-05 | 210061 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-02-09 | 2022-03-15 | 154523 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-19 | 2022-11-29 | 167366 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-19 | 2022-11-29 | 167369 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-03-03 | 2023-04-05 | 186160 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-09-11 | 2023-10-11 | 204118 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-12-12 | 2023-02-01 | 177931 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-11-16 | 2022-11-17 | 174901 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-10-04 | 2022-10-20 | 171063 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2023-03-03 | 2023-03-14 | 186163 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |